Medical Qualifications
Dr Robin Ireland qualified in 1977 from the University of London with a Bachelor of Medicine and Bachelor of Surgery degree. In 1979 he became a Member of the Royal College of Physicians of England and in 1987 a Member of the Royal College of Pathologists. Dr Ireland was awarded Fellowship of the Royal College of Physicians in 1996 and Fellowship of the Royal College of Pathologists in 1998.
Medical Experience
Dr Ireland is a member of a number of societies including the British Society for Haematology, American Society of Haematology, European Leukemia Network, MDS Flow Cytometry Working Group, UK MDS Forum and the Haematology Site-Specific Reference Group of the National Cancer Intelligence Network.
Dr Ireland has a wide experience in general haematology and malignant diseases in both secondary and tertiary care settings, having previously worked at the Queen Elizabeth Hospital, Woolwich from 1989 to 2007. He is currently the Lead Clinician for the King’s Haematological Malignancy Diagnostic Centre (KHMDC), set up in 2007 which provides specialist diagnostic services for haematological cancers and bone marrow failure syndromes to a population of approximately 4.5 million in South East England. Clinical activities at King’s include investigation and management of general haematology and myeloid disorders especially myelodysplasia.
Dr Ireland is a Consultant Haematologist at King's College Hospital NHS Trust. He is college examiner and representative at consultant advisory appointment boards for the Royal College of Pathologists and is External Examiner to the University of York. Dr Ireland is available for private patients at The London Bridge Hospital.
Dr Robin M Ireland's Places of Practice
If you would like to make an appointment with Dr Robin M Ireland please click the button below
If you would like to arrange a private appointment with Dr Robin M Ireland please complete the fields below, we will contact you shortly to make the arrangements.
We are committed to safeguarding your personal information, please read our Privacy Policy for full details.